Canada Pension Plan Investment Board’s Cidara Therapeutics CDTX Stock Holding History

Canada Pension Plan Investment Board’s Portfolio CDTX Stock Details CDTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-2,200	Closed	-$486K	–	1735
2025 Q4	$486K	Buy	+2,200	New	+$356K	﹤0.01%	1312

Canada Pension Plan Investment Board's CDTX Position: Q1 2026 in Review

Canada Pension Plan Investment Board sold out of Cidara Therapeutics (CDTX) in Q1 2026, closing a stake of 2,200 shares — an estimated $486K sold.

Canada Pension Plan Investment Board first reported a position in CDTX in Q4 2025 and held it in 1 quarter. The position peaked at $486K in Q4 2025. 0 funds tracked by Wall St. Rank hold CDTX as of Q1 2026.

Canada Pension Plan Investment Board reported no remaining Cidara Therapeutics position as of Q1 2026 after selling out during the quarter.
Canada Pension Plan Investment Board sold 2,200 Cidara Therapeutics shares in Q1 2026, an estimated $486K.
Canada Pension Plan Investment Board first reported a position in Cidara Therapeutics in Q4 2025 and held it in 1 quarter.
Canada Pension Plan Investment Board's Cidara Therapeutics position peaked at $486K in Q4 2025.
0 funds tracked by Wall St. Rank held Cidara Therapeutics as of Q1 2026.

Based on Canada Pension Plan Investment Board's 13F filing for Q1 2026, filed 15 May 2026.